Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Biaxin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
6739 Background: Levels of serum sIL-2R represents the total amount of activated T lymphocytes in tumor infiltrating lymphocytes… Expand
2004
2004
OBJECTIVE To report the first comprehensive analysis of clarithromycin (CLA) and 14-(R)-hydroxyclarithromcin (14R) bioequivalence… Expand
2003
2003
Many antibiotic monographs cite the induction of vaginal infections as a possible side effect. Invariably, this is believed to be… Expand
Review
2003
Review
2003
AbstractAbstractClarithromycin is an orally active, advanced-generation macrolide that has been reformulated as an extended… Expand
Review
2003
Review
2003
  • M. Gotfried
  • Expert review of anti-infective therapy
  • 2003
  • Corpus ID: 24498185
Clarithromycin (Biaxin®) extended-release tablets, an advanced generation macrolide, were recently introduced into the USA for… Expand
2000
2000
OBJECTIVE To assess the bioequivalence of two tablet formulations of clarithromycin (Clamicin 500 mg from Medley Indlistria… Expand
1998
1998
  • Grübel, Cave
  • Alimentary pharmacology & therapeutics
  • 1998
  • Corpus ID: 39759220
Factors influencing the pharmacokinetics of clarithromycin in gastric mucus are poorly defined. 
1995
1995